ARCHIVES

CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years

This article is from The Cancer Letter archive.

Vol. 25 No. 15 | April 16, 1999

Download PDF Visit The Full Archive

Related Articles

Another Potti Paper Retracted

September 16, 2011

NIH Director’s Office Funds $106 Million In Cancer Grants With Stimulus Dollars

September 18, 2009

Business & Regulatory Report March edition (8 pages) included.

March 19, 2004

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

Funding Opportunities.

April 11, 2003

DCT Board Approves Concepts Of Five Contract Recompetitions

October 14, 1983